11q Deletion Is Not a Prognostic Factor for Ad... - CLL Support

CLL Support

22,508 members • 38,657 posts

11q Deletion Is Not a Prognostic Factor for Adverse Outcomes for Patients with CLL treated with ibrutinib

7 years ago•3 Replies

You need to be a member of this community to see this post.

Read more about...

Ibrutinib

3 Replies

You need to be a member of this community to see hidden responses.

You may also like...

RICHTER'S TRANSFORMATION IN PATIENTS WITH CLL: ANALYSIS OF BIOLOGICAL AND CLINICAL RISK FACTORS AND OUTCOMES

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): ANALYSIS OF BIOLOGICAL AND CLINICAL RISK FACTORS AND OUTCOMES...

zevkalman•10 years ago

Are there possibilities other than stem cell transplant in Canada for CLL with 11Q deletion?

My son lives in Canada. He has CLL stage 4 with 11Q deletion. He was taken off Ibrutinib because his

karenmarie•8 years ago

Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL

only is CLL heterogeneous in watch and wait, that's also the case after treatment. An analysis of...

AussieNeilAdministrator•5 years ago

quinine to treat cramps and cll patients.

husband has been given two different opinions, one the cll consultant saying quinine should be...

lartington•10 years ago

Health Canada approves Ibrutinib plus Rituximab for First Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

improved progression-free survival (PFS) compared to patients treated with fludarabine,...

AussieNeilAdministrator•3 years ago